Clinical trial Recruiting at 1 site Phase 3 Interventional Ages Any age to 18

Testing Nucleo CMP Forte for treating pediatric traumatic brain injuries

Official title: Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial

Run by Tanta University · NCT04499755 · Data updated 2026-11-12

This study is testing if Nucleo CMP Forte can help children with moderate to severe traumatic brain injuries recover better.

Quick facts

PhasePhase 3
Study typeInterventional
AgesAny age to 18 Years
SexAll
Enrollment100 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta)
StatusRecruiting
StartedJune 1, 2020
Main results expectedDecember 1, 2030
Study endsDecember 10, 2030
Registry record updatedAugust 5, 2020
Trial IDNCT04499755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children diagnosed with moderate to severe traumatic brain injuries.

Probably not a fit

Patients with underlying central nervous system disorders may not benefit from this treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy of Nucleo CMP Forte in children suffering from moderate to severe traumatic brain injuries. It is a Phase 3 interventional trial that aims to determine how well this treatment works in improving outcomes for pediatric patients. The study will involve administering Nucleo CMP Forte and monitoring its effects on recovery and brain function. The goal is to provide evidence for its effectiveness in this vulnerable population.

Why it matters

Potential benefit: If successful, this treatment could significantly improve recovery outcomes for children with traumatic brain injuries.

How similar studies have gone: There is limited information on similar studies, making this approach relatively novel in the context of pediatric traumatic brain injury.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children with traumatic brain injury: Moderate and Severe.

Exclusion Criteria:

* Underlying CNS disorders,

Where it's running

  • Sherief Abd-Elsalam
    Tanta, Egypt
    Recruiting

Study contacts

  • Principal investigator: Abeer Salamah, Lecturer — Pediatrics department - Kafr-Elsheikh University
  • Study coordinator: Sherief Abd-Elsalam, ass. prof.
  • Email: sheriefabdelsalam@yahoo.com
  • Phone: 00201147773440

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.